Option Care Health, Inc. (NASDAQ:OPCH) Given Average Recommendation of "Moderate Buy" by Analysts

Option Care Health, Inc. (NASDAQ:OPCH - Get Free Report) has earned an average recommendation of "Moderate Buy" from the eight analysts that are currently covering the stock, Marketbeat reports. One investment analyst has rated the stock with a hold rating and seven have issued a buy rating on the company. The average 1-year price objective among brokers that have issued a report on the stock in the last year is $35.50.

Several research firms recently commented on OPCH. UBS Group upgraded Option Care Health from a "neutral" rating to a "buy" rating and lifted their price objective for the stock from $38.00 to $40.00 in a report on Wednesday, April 30th. JMP Securities reiterated a "market outperform" rating and issued a $36.00 price objective on shares of Option Care Health in a report on Wednesday, June 18th. Finally, Barrington Research reiterated an "outperform" rating and issued a $38.00 price objective on shares of Option Care Health in a report on Thursday.

Institutional Investors Weigh In On Option Care Health

Large investors have recently made changes to their positions in the company. Wedge Capital Management L L P NC lifted its position in shares of Option Care Health by 12.8% during the 2nd quarter. Wedge Capital Management L L P NC now owns 133,389 shares of the company's stock valued at $4,332,000 after buying an additional 15,102 shares in the last quarter. Financiere des Professionnels Fonds d investissement inc. purchased a new position in shares of Option Care Health during the 2nd quarter valued at about $231,000. Assenagon Asset Management S.A. lifted its position in shares of Option Care Health by 227.1% during the 2nd quarter. Assenagon Asset Management S.A. now owns 635,758 shares of the company's stock valued at $20,649,000 after buying an additional 441,417 shares in the last quarter. Livforsakringsbolaget Skandia Omsesidigt purchased a new position in shares of Option Care Health during the 2nd quarter valued at about $3,182,000. Finally, Fiduciary Financial Group LLC purchased a new position in shares of Option Care Health during the 2nd quarter valued at about $315,000. 98.05% of the stock is currently owned by institutional investors.

Option Care Health Price Performance

Shares of NASDAQ:OPCH opened at $29.88 on Friday. Option Care Health has a 1-year low of $21.39 and a 1-year high of $35.53. The company has a debt-to-equity ratio of 0.82, a current ratio of 1.54 and a quick ratio of 1.02. The business has a fifty day moving average price of $31.80 and a 200-day moving average price of $31.36. The company has a market capitalization of $4.89 billion, a PE ratio of 24.10, a PEG ratio of 1.84 and a beta of 0.73.

Option Care Health (NASDAQ:OPCH - Get Free Report) last issued its quarterly earnings results on Tuesday, April 29th. The company reported $0.40 earnings per share for the quarter, beating the consensus estimate of $0.36 by $0.04. Option Care Health had a return on equity of 16.90% and a net margin of 4.12%. The firm had revenue of $1.33 billion during the quarter, compared to the consensus estimate of $1.26 billion. During the same period last year, the company earned $0.26 earnings per share. The company's revenue was up 16.3% on a year-over-year basis. As a group, equities analysts expect that Option Care Health will post 1.22 EPS for the current fiscal year.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.